, Volume 205, Issue 2, pp 319–326 | Cite as

Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat–an animal model of attention deficit hyperactivity disorder

  • Pablo Pandolfo
  • Leandro F. Vendruscolo
  • Regina Sordi
  • Reinaldo N. TakahashiEmail author
Original Investigation



Cannabis preparations are the most widely consumed illicit drugs, and their use typically begins in adolescence. The prevalence of cannabis abuse is higher in patients with attention deficit/hyperactivity disorder (ADHD) than in the general population, yet, knowledge about the motivational properties of cannabinoids in animal models of ADHD are lacking.


To compare the motivational effects of the synthetic cannabinoid agonist WIN55,212-2 (WIN) in adolescent and adult spontaneously hypertensive rats (SHR), a validated animal model of ADHD, and Wistar rats, representing a “normal” genetically heterogeneous population. We also asked whether the effects of WIN depended (1) on the activation of the cerebral subtype of cannabinoid receptors, namely, the CB1 cannabinoid receptor and (2) on putative changes by WIN in blood pressure.


WIN was tested under an unbiased conditioned place preference (CPP) paradigm. Blood pressure after WIN administration was also monitored in additional groups of rats.


In the Wistar rats, WIN produced place aversion only in the adult but not adolescent rats. In contrast, WIN produced CPP in both adolescent and adult SHR rats. The behavioral effects of WIN were CB1-mediated and not related to blood pressure.


The contrasting effects of WIN in Wistar and SHR, and the higher resistance of adolescent rats to the aversive and rewarding effects of WIN in these two strains suggests that both adolescence and the ADHD-like profile exhibited by the SHR strain constitute factors that influence the motivational properties of cannabinoids.


Attention deficit hyperactivity disorder (ADHD) Drug addiction Adolescence Cannabinoid system Dopamine Reward Aversion Conditioned place preference Inbred strain Spontaneously hypertensive rat (SHR) 



The authors are grateful to Dr. Jamil Assreuy for his expert assistance in blood pressure measurements and to Dr. Attila Köfalvi and Dr. Kelly J. Clemens for helpful comments. P.P. and R.S. are supported by scholarships from CNPq, Brazil. L.F.V. had a post-doctoral fellowship from FONDATION FYSSEN, France. R.N.T. is the holder of a CNPq fellowship.


  1. Adriani W, Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol. 2004;15:341–352.PubMedCrossRefGoogle Scholar
  2. Adriani W, Seta DD, Dessi-Fulgheri F, Farabollini F, Laviola G. Altered profiles of spontaneous novelty seeking, impulsive behavior, and response to d-amphetamine in rats perinatally exposed to bisphenol A. Environ Health Perspect. 2003;111:395–401.PubMedGoogle Scholar
  3. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci. 2002;5:13–14.PubMedCrossRefGoogle Scholar
  4. Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder. Behav Brain Res. 2006;167:379–382.PubMedCrossRefGoogle Scholar
  5. Batkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J, et al. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation. 2004;110:1996–2002.PubMedCrossRefGoogle Scholar
  6. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res. 1994;53:13–29.PubMedCrossRefGoogle Scholar
  7. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36:167–179.PubMedCrossRefGoogle Scholar
  8. Braida D, Iosue S, Pegorini S, Sala M. Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol. 2004;506:63–69.PubMedCrossRefGoogle Scholar
  9. Carney JM, Uwaydah IM, Balster RL. Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey. Pharmacol Biochem Behav. 1977;7:357–364.PubMedCrossRefGoogle Scholar
  10. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160:1041–1052.PubMedCrossRefGoogle Scholar
  11. Chiu P, Rajakumar G, Chiu S, Kwan CY, Mishra RK. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR). Eur J Pharmacol. 1982;82:243–244.PubMedCrossRefGoogle Scholar
  12. Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav. 2007;86:189–199.PubMedCrossRefGoogle Scholar
  13. Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend. 1998;50:27–37.PubMedCrossRefGoogle Scholar
  14. Da Silva GE, Vendruscolo LF, Takahashi RN. Effects of ethanol on locomotor and anxiety-like behaviors and the acquisition of ethanol intake in Lewis and spontaneously hypertensive rats. Life Sci. 2005;77:693–706.PubMedCrossRefGoogle Scholar
  15. Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev. 2003;42:1–21.PubMedCrossRefGoogle Scholar
  16. Deiana S, Fattore L, Spano MS, Cossu G, Porcu E, Fadda P, et al. Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats. Neuropharmacology. 2007;52:646–654.PubMedCrossRefGoogle Scholar
  17. Fattore L, Cossu G, Martellotta CM, Fratta W. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55, 212–2 in rats. Psychopharmacology (Berl). 2001;156:410–416.CrossRefGoogle Scholar
  18. Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D, et al. Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl). 1988;96:142–144.CrossRefGoogle Scholar
  19. Himelstein J, Newcorn JH, Halperin JM. The neurobiology of attention-deficit hyperactivity disorder. Front Biosci. 2000;5:461–478.CrossRefGoogle Scholar
  20. Hoffmann O, Plesan A, Wiesenfeld-Hallin Z. Genetic differences in morphine sensitivity, tolerance and withdrawal in rats. Brain Res. 1998;806:232–237.PubMedCrossRefGoogle Scholar
  21. Justinova Z, Tanda G, Redhi GH, Goldberg SR. Self-administration of delta(9)-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl). 2003;169:135–140.CrossRefGoogle Scholar
  22. Köfalvi A, Fritzsche M (2008) The Endocannabinoid System is a Major Player in Schizophrenia. In: Köfalvi, A. (Ed.), Cannabinoids and the Brain. Springer US, pp. 485-528. doi: 10.1007/978-0-387-74349-3_22
  23. Lake KD, Compton DR, Varga K, Martin BR, Kunos G. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther. 1997;281:1030–1037.PubMedGoogle Scholar
  24. Leite JR, Carlini EA. Failure to obtain “cannabis-directed behavior” and abstinence syndrome in rats chronically treated with cannabis sativa extracts. Psychopharmacologia. 1974;36:133–145.PubMedCrossRefGoogle Scholar
  25. Lepore M, Vorel SR, Lowinson J, Gardner EL. Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci. 1995;56:2073–2080.PubMedCrossRefGoogle Scholar
  26. Maharajan P, Maharajan V, Ravagnan G, Paino G. The weaver mutant mouse: a model to study the ontogeny of dopamine transmission systems and their role in drug addiction. Prog Neurobiol. 2001;64:269–276.PubMedCrossRefGoogle Scholar
  27. Maldonado R, Valverde O, Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006;29:225–232.PubMedCrossRefGoogle Scholar
  28. Mansbach RS, Nicholson KL, Martin BR, Balster RL. Failure of Delta(9)-tetrahydrocannabinol and CP 55, 940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. Behav Pharmacol. 1994;5:219–225.PubMedCrossRefGoogle Scholar
  29. Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W. Self-administration of the cannabinoid receptor agonist WIN 55, 212–2 in drug-naive mice. Neuroscience. 1998;85:327–330.PubMedCrossRefGoogle Scholar
  30. McGregor IS, Issakidis CN, Prior G. Aversive effects of the synthetic cannabinoid CP 55, 940 in rats. Pharmacol Biochem Behav. 1996;53:657–664.PubMedCrossRefGoogle Scholar
  31. McKeon TW, Hendley ED. Brain monoamines and metabolites in hypertensive and hyperactive rat strains. Clin Exp Hypertens. 1988;10:971–994.Google Scholar
  32. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1963;27:282–293.PubMedGoogle Scholar
  33. Pamplona FA, Prediger RD, Pandolfo P, Takahashi RN. The cannabinoid receptor agonist WIN 55, 212–2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl). 2006;188:641–649.CrossRefGoogle Scholar
  34. Pamplona FA, Vendruscolo LF, Takahashi RN. Increased sensitivity to cocaine-induced analgesia in Spontaneously Hypertensive Rats (SHR). Behav Brain Funct. 2007;3:9.PubMedCrossRefGoogle Scholar
  35. Pandolfo P, Pamplona FA, Prediger RD, Takahashi RN. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55, 212–2. Eur J Pharmacol. 2007;563:141–148.PubMedCrossRefGoogle Scholar
  36. Papa M, Diewald L, Carey MP, Esposito FJ, Gironi Carnevale UA, Sadile AG. A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system. Behav Brain Res. 2002;130:171–179.PubMedCrossRefGoogle Scholar
  37. Parker LA, Gillies T. THC-induced place and taste aversions in Lewis and Sprague–Dawley rats. Behav Neurosci. 1995;109:71–78.PubMedCrossRefGoogle Scholar
  38. Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, et al. Adolescent rats find repeated delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology. 2008;33:1113–1126.PubMedCrossRefGoogle Scholar
  39. Ramos A, Kangerski AL, Basso PF, Da Silva Santos JE, Assreuy J, Vendruscolo LF, et al. Evaluation of Lewis and SHR rat strains as a genetic model for the study of anxiety and pain. Behav Brain Res. 2002;129:113–123.PubMedCrossRefGoogle Scholar
  40. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA. 2002;99:8384–8388.PubMedCrossRefGoogle Scholar
  41. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder—the spontaneously hypertensive rat. Brain Res. 1995;676:343–351.PubMedCrossRefGoogle Scholar
  42. Russell VA, de Villiers AS, Sagvolden T, Lamm MC, Taljaard JJ. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder–the spontaneously hypertensive rat. Brain Res Bull. 2000;53:187–192.PubMedCrossRefGoogle Scholar
  43. Russell VA, Sagvolden T, Johansen EB. Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct. 2005;1:9.PubMedCrossRefGoogle Scholar
  44. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev. 2000;24:31–39.PubMedCrossRefGoogle Scholar
  45. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1239–1247.PubMedCrossRefGoogle Scholar
  46. Sanudo-Pena MC, Tsou K, Delay ER, Hohman AG, Force M, Walker JM. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett. 1997;223:125–128.PubMedCrossRefGoogle Scholar
  47. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 2000;24:417–463.PubMedCrossRefGoogle Scholar
  48. Spear LP, Brake SC. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol. 1983;16:83–109.PubMedCrossRefGoogle Scholar
  49. Takahashi RN, Singer G. Self-administration of delta 9-tetrahydrocannabinol by rats. Pharmacol Biochem Behav. 1979;11:737–740.PubMedCrossRefGoogle Scholar
  50. Tanda G, Munzar P, Goldberg SR. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci. 2000;3:1073–1074.PubMedCrossRefGoogle Scholar
  51. Taylor E. Clinical foundations of hyperactivity research. Behav Brain Res. 1998;94:11–24.PubMedCrossRefGoogle Scholar
  52. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol. 2007;12:227–462.PubMedCrossRefGoogle Scholar
  53. Valjent E, Maldonado R. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl). 2000;147:436–438.CrossRefGoogle Scholar
  54. van Ree JM, Slangen JL, de Wied D. Intravenous self-administration of drugs in rats. J Pharmacol Exp Ther. 1978;204:547–557.PubMedGoogle Scholar
  55. Vendruscolo LF, Izidio GS, Takahashi RN, Ramos A. Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats. Behav Pharmacol. 2008;19:21–27.PubMedCrossRefGoogle Scholar
  56. Vendruscolo LF, Izídio GS, Takahashi RN. Drug reinforcement in a rat model of attention deficit/hyperactivity disorder – the spontaneously hypertensive rat (SHR). Current Drug Abuse Reviews. 2009, in pressGoogle Scholar
  57. Viggiano D, Vallone D, Ruocco LA, Sadile AG. Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci Biobehav Rev. 2003;27:683–689.PubMedCrossRefGoogle Scholar
  58. Vlachou S, Nomikos GG, Panagis G. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology (Berl). 2005;179:498–508.CrossRefGoogle Scholar
  59. Vlachou S, Nomikos GG, Stephens DN, Panagis G. Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav Pharmacol. 2007;18:311–319.PubMedCrossRefGoogle Scholar
  60. Watanabe Y, Fujita M, Ito Y, Okada T, Kusuoka H, Nishimura T. Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med. 1997;38:470–474.PubMedGoogle Scholar
  61. Wheal AJ, Bennett T, Randall MD, Gardiner SM. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. Br J Pharmacol. 2007;152:717–724.PubMedCrossRefGoogle Scholar
  62. Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA. Two brain sites for cannabinoid reward. J Neurosci. 2006;26:4901–4907.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Pablo Pandolfo
    • 1
  • Leandro F. Vendruscolo
    • 2
  • Regina Sordi
    • 1
  • Reinaldo N. Takahashi
    • 1
    • 3
    Email author
  1. 1.Departamento de Farmacologia, Centro de Ciências BiológicasUniversidade Federal de Santa Catarina (UFSC)FlorianópolisBrazil
  2. 2.CNRS-UMR 5227Université Bordeaux 1 et 2BordeauxFrance
  3. 3.Departamento de FarmacologiaUniversidade Federal de Santa CatarinaFlorianópolisBrazil

Personalised recommendations